Biologics

Thermo Fisher Scientific to Further Expand Global Network of Single-Use Technology Manufacturing Sites

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced plans to establish a manufacturing facility in Nashvil...

 September 10, 2021 | News

RMG-KB BIOACCESS FUND LAUNCHES with Worldwide Focus on Innovative Life Sciences Ventures

This latest fund represents a significant expansion of the principal investment business of RMG, building on the team's 25-plus year history in life scienc...

 September 08, 2021 | News

China to provide a best-in-class CAR-T therapy

The first CAR-T product independently developed in China and approved as a Category 1 biologics product, and the sixth approved CAR-T product g...

 September 07, 2021 | News

GenScript ProBio to Manufacture Innovative Antibody Drug

FLYSYN is a fms-like tyrosine kinase 3 (FLT3) specific antibody for the treatment of acute myeloid leukemia (AML) patients in complete remission. FLYSYN wa...

 September 06, 2021 | News

Thermo Fisher Scientific and AstraZeneca to Co-Develop NGS-based Companion Diagnostics

Thermo Fisher Scientific's clinical sequencing business and AstraZeneca today announced they will co-develop next-generation sequencing (NGS)-based compani...

 September 02, 2021 | News

Cryoport,Mitsubishi Partner to Bring Temperature-Controlled Supply Chain Solutions to Asia-Pacific

Cryoport and MLC will partner to create synergistic value by leveraging each other's global logistics networks. The partnership will provide integrated, en...

 August 26, 2021 | News

Quotient Sciences Announces Multimillion-Pound Investment in Drug Substance Manufacturing Facility

 The investment will significantly expand Quotient’s drug substance manufacturing capability and will create 80 new jobs over the next three yea...

 August 25, 2021 | News

Mycenax Biotech builds first continuous bioprocessing lab in Taiwan with Cytiva

Cytiva, a global life sciences leader, has partnered with Mycenax Biotech Inc, a leading biopharmaceutical CDMO company, to launch Taiwan’s first con...

 August 23, 2021 | News

JW Therapeutics Announces Strategic Partnership with MediTrust Health

Leveraging the respective business advantages, both parties plan to strengthen cooperation in supplementary medical insurance and health insurance policy, ...

 August 23, 2021 | News

Standigm Expands Global Footprints with New Office in Cambridge, UK

Founded in 2015, Standigm has proprietary technology including AI platforms encompassing novel target identification to novel compound design to generate c...

 August 20, 2021 | News

Senhwa's Silmitasertib Receives US FDA Fast Track Designation

Senhwa Biosciences, Inc., a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today ann...

 August 19, 2021 | News

Senhwa Signs Agreement with Taiwan's CDE for COVID-19 Program

Taiwan's CDE is an instrumental partner of the Taiwan Food and Drug Administration (TFDA), assisting in drafting regulations and guidance, while ...

 August 14, 2021 | News

Strengthening Australia’s regenerative medicine value chain

The Australian biotech sector is actively considering how it can support greater access to ground-breaking therapies for Australians, as RM challenges the ...

 August 13, 2021 | News

Life Sciences' Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Frost & Sullivan's recent analysis finds that digital therapeutics (DTx) in the United States are considered legitimate alternatives to tradi...

 August 10, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close